HNN227 Increased Vascular Permeability and Inflammation

Definition and Nature of Inflammation

  • General Definition: Inflammation is characterized as a nonspecific, localized, protective reaction of biological tissue responding to irritation, injury, or infection.

  • The Nonspecific Property: The inflammatory response is termed "nonspecific" because the physiological process remains the same regardless of the underlying cause. The response is identical whether the cell injury is triggered by:

    • Physical agents.

    • Chemical agents.

    • Ischemic events.

    • Infectious agents.

Purpose and Classification of the Inflammatory Response

  • Primary Objectives: The fundamental goals of the inflammatory process are threefold:

    • To quickly neutralize the injurious agent.

    • To stop the progression of further cell damage.

    • To clean up the tissue site, thereby enabling the completion of the healing process.

  • Acute Inflammation: This is the early, almost immediate reaction of tissue to an injury. It is formally classified as the first stage of wound healing.

  • Chronic Inflammation: This state occurs if the agent of injury persists over time, causing the inflammatory response to become prolonged.

Basic Components and Cardinal Signs

  • Essential Components: The inflammatory process involves three basic physiological events:

    • Vasodilation (widening of blood vessels).

    • Increased vascular permeability.

    • Immigration of white blood cells (leukocytes) to the site of injury.

  • The Five Cardinal Signs: These represent the clinical manifestations of inflammation:

    • 1. Redness.

    • 2. Warmth.

    • 3. Swelling.

    • 4. Pain.

    • 5. Loss of function.

The Vascular Response and Chemical Mediators

  • Immediate Reaction: When cell injury occurs, there is an initial, momentary period of vasoconstriction.

  • Release of Pro-inflammatory Mediators: Damaged tissues release specific chemical signals to initiate the response, including:

    • Histamines.

    • Kinins.

    • Prostaglandins.

  • Vasodilation and Warmth: These mediators trigger localized vasodilation. This increases blood flow to the affected area, which is the physiological cause of the increased warmth felt in the tissue.

  • Vascular Permeability and Exudate:

    • The mediators induce capillaries to increase their permeability.

    • Mechanism: This is achieved by increasing the gap between the endothelial cells that form the capillary walls. This gap allows plasma to move out of the vessel and into the interstitial fluid. The fluid that moves into the tissue, carrying important substances for the inflammatory response, is known as exudate.

    • Function: The movement of this fluid helps to dilute localized toxins.

    • Clinical Observation: The increase in permeability and subsequent fluid shift accounts for the localized swelling.

Hemodynamic Changes, Pain, and Loss of Function

  • Viscosity and Redness: As plasma fluid leaves the capillary and enters the tissue, the blood remaining in the circulatory system becomes more viscous (thicker). This leads to two specific outcomes:

    • The blood is enabled to clot more easily.

    • The blood flows more slowly.

    • This slowed, concentrated blood flow accounts for the increased redness in the area.

  • The Mechanisms of Pain:

    • Physical Stimulus: Swelling increases the internal tissue pressure, which mechanically stimulates nociceptors (pain receptors).

    • Chemical Stimulus: Certain chemical mediators—specifically bradykinin and prostaglandins—directly increase the frequency of pain transmissions sent to the brain.

    • Result: This biochemical and mechanical combination heightens the sensation of pain.

  • Loss of Function: The resulting pain and swelling can lead to a subsequent loss of function in the affected area.

Cellular Response Mechanisms in Tissue Injury

  • Recruitment of White Blood Cells (WBCs): The cellular response is initiated when chemical mediators draw white blood cells to the site of tissue injury. Leukocytes are capable of squeezing through existing gaps in the capillary walls to exit the bloodstream and enter the inflamed tissue.

  • Leukocyte Classifications: The primary leukocytes involved in this response include:

    • Neutrophils.

    • Monocytes.

    • Lymphocytes.

    • Macrophages.

  • Chemotaxis: This is the process by which leukocytes move through the tissue toward the site of injury by following chemical gradients.

  • Phagocytosis: The culmination of the cellular response where phagocytes (specialized leukocytes) engulf and degrade bacteria and cellular debris.

  • Exudate Formation: The products resulting from phagocytosis, combined with plasma and other blood cells, form a substance known as exudate. This collection of fluid and cells contributes directly to the clinical manifestations of swelling and pain.

Chemical Mediators of Inflammation

  • Cell-Derived Mediators: Chemicals released directly from cells to facilitate the inflammatory response include:

    • Histamine.

    • Serotonin.

    • Prostaglandin.

  • Plasma-Derived Mediators: Chemicals originating from the blood plasma that assist in mediating inflammation include:

    • Bradykinin.

    • The clotting system.

    • The complement system.

Management and Treatment of Inflammation

  • Determination of Treatment: The specific treatment for inflammation is dictated by several factors:

    • The location of the inflammation within the body.

    • The underlying cause (e.g., autoimmune response, direct physical injury, or infection).

  • Pharmacological Management: Medications used to manage inflammation include:

    • Non-steroidal anti-inflammatory drugs (NSAIDs) (prevent prostaglandins from being synthesised)

    • Aspirin

    • Paracetamol

    • Corticosteroids: These medications function by binding to glucocorticoid receptors to suppress the inflammatory response.

  • Non-Pharmacological Treatments: Often referred to as the RICE protocol and lifestyle interventions:

    • Rest.

    • Ice.

    • Compression.

    • Elevation.

    • Adequate nutrition, specifically including anti-inflammatory foods.

Nature and Pathogenesis of Infection

  • Definition: Infection is characterized as the invasion and multiplication of microorganisms within body tissue.

  • Infectious Agents: Infections are caused by various pathogens and their metabolic byproducts, including:

    • Bacteria.

    • Viruses.

    • Parasites.

    • Fungi.

    • Toxic products produced by these pathogens.

  • Modes of Transmission:

    • Direct: Contact with infected blood and body fluids.

    • Indirect: Through contaminated water, food, or surfaces (fomites).

    • Vectors: Via intermediate organisms, such as mosquitoes.

  • Vulnerable Populations: Certain groups are at a higher risk of infection, including:

    • The elderly.

    • Individuals with chronic diseases.

    • Patients on immunosuppressant therapy.

    • Patients undergoing chemotherapy.

    • Young children.

Body Defense Mechanisms

  • Physical Barriers: The first line of defense includes:

    • Skin.

    • Mucous membranes.

    • Tears and earwax.

    • Stomach acid.

    • Urine and vaginal secretions.

    • Antimicrobial factors present in saliva, tears, and prostatic fluids.

  • Respiratory Defenses: Specific mechanisms within the respiratory system include:

    • Humidification.

    • Filtration.

    • The mucociliary lining.

  • Mechanical Clearing: The flushing actions of the urinary tract and the bowel help expel pathogens.

The Chain of Infection and Clinical Outcomes

  • The Chain of Infection: For an infection to occur, a specific six-step chain must be established:

    1. A causative agent.

    2. A source for the agent.

    3. A portal of exit from that source.

    4. A means of transmission.

    5. A portal of entry into the new host.

    6. A susceptible person.

  • Post-Invasion Outcomes: Once microorganisms successfully invade the body, they must multiply. Following multiplication, three primary outcomes are possible:

    1. The microorganisms continue to multiply and overwhelm the host's defenses.

    2. A state of balance is reached, resulting in a chronic infection.

    3. The body, either through its own means or with medical intervention, destroys and eliminates the invading microorganisms.

Virulence and Evasion of Immune Defenses

  • Virulence Factors: Specialized molecules or properties of disease-causing microorganisms that increase the severity of the disease they cause.

  • Evasion Tactics: Microorganisms have evolved various ways to bypass body defenses:

    • Blocking physical or chemical defense mechanisms.

    • Interfering with the production of antibodies and T cells.

    • Using capsules: Protective outer layer coats that prevent white blood cells from ingesting the microorganism and causing lysis

  • Biofilms: Some bacteria produce a biofilm that allows them to attach to host cells and foreign materials, such as:

    • Peripheral IVC (Intravenous Catheters).

    • Suture material.

    • Medical implants.

  • Biofilm Function: Biofilms protect microorganisms from being reached by the host immune response and from the effects of antibiotics.

Host Physiological Response to Infection

  • Immune Identification: White blood cells and antibodies identify and eliminate pathogens that have successfully bypassed physical barriers.

  • Cellular Proliferation: The body increases the count of specific white blood cells, namely neutrophils and monocytes, to engulf and destroy invaders.

  • Killer T Cells: The immune system produces these specialized white blood cells to recognize and kill invading organisms directly.

  • Antibody Function: Antibodies attach to microorganisms to immobilize them, kill them outright, or assist neutrophils in targeting them.

  • Fever: An increase in body temperature is a protective response to both infection and injury.

Clinical Manifestations of Infection

  • Systemic (Whole Body) Symptoms: These indicate the infection has spread or is affecting the entire system:

    • Fatigue.

    • Loss of appetite and weight loss.

    • Fevers, night sweats, and chills.

    • Aches and pains.

    • Tachycardia (elevated heart rate).

    • Tachypnea (elevated respiratory rate).

  • Localized Symptoms: These are specific to the site of infection or entry:

    • Skin rashes.

    • Coughing.

    • Runny nose.

Pathophysiology and Localization of Pneumonia

  • Pneumonia is defined as an inflammatory condition of the lung.

  • It primarily affects the bronchioles and the microscopic air sacs known as the alveoli.

  • The inflammatory response is typically the result of infection by pathogens, including bacteria and viruses.

  • Severity and localization:

    • The condition may affect one or more lobes of the lung.

    • It can manifest in either one or both lungs.

    • The specific location is determined using diagnostic methods including chest x-ray or auscultation.

Classification and Natural Defenses of the Respiratory System

  • Categorization by setting of acquisition:

    • Community-acquired pneumonia (CAP).

    • Hospital-acquired pneumonia (HAP).

    • Ventilator-associated pneumonia (VAP).

    • Aspiration pneumonia.

  • Natural state of the alveoli:

    • Under normal conditions, alveoli are sterile, air-filled stacks.

    • They are covered by many tiny capillaries and serve as the primary site of gas exchange.

    • In healthy lungs, the surface area of the alveoli is very large, which facilitates the rate of gas exchange necessary to maintain oxygenation levels and effective CO2CO_2 clearance.

  • Defense mechanisms against infection:

    • A healthy immune system.

    • The ability to cough and swallow effectively.

    • A fully functioning mucociliary clearance system.

Compromised Defenses and Mucociliary Function

  • Factors reducing or compromising defense mechanisms:

    • Recent illness or surgery.

    • Presence of pain.

    • Prolonged bed rest leading to decreased mobility.

  • Mechanism of Mucocellar clearance:

    • The lining of the trachea, bronchi, and bronchioles is composed of cells that produce mucus.

    • These linings feature cilia, hair-like structures that protrude outward.

    • Purpose: These features trap pathogens and other particles, sweeping them upward toward the throat where they are swallowed or coughed up.

    • Impairment: Smoking can impair this system as it paralyzes or destroys the cilia.

Mechanisms of Alveolar Infection and Consolidation

  • Bacterial impact on alveoli:

    • Alveoli are nutrient-rich, creating an environment where bacteria can multiply at a very high rate.

  • The inflammatory process:

    • Inflammation of the alveoli occurs as part of the infective process.

    • Fluid, white blood cells, and sometimes red blood cells enter the alveoli.

    • Infecting microorganisms are diluted by fluid and attacked by red blood cells, creating cellular wreckage or pus.

  • Consequences of inflammation:

    • Consolidation: A state where the alveoli are filled with liquid and pus instead of air.

    • Atelectasis: The collapse of some of the alveoli.

    • Reduced compliance: Inflammation causes lung tissue to stiffen, decreasing the lungs' capability to expand normally.

  • Respiratory impact:

    • Consolidation, collapse, and stiffening lead to the affected area becoming unventilated.

    • This reduces the surface area for gas exchange, causing the process to become impaired.

    • Ultimately, this leads to decreased tissue perfusion.

Clinical Signs, Symptoms, and Assessment of Pneumonia

  • Assessment findings and signs:

    • Tachypnea and shortness of breath.

    • Use of accessory muscles for breathing.

    • Decreased oxygen saturations (SpO2SpO_2).

    • Restlessness, agitation, and confusion.

    • Productive cough and tachycardia.

    • Chest pain and discomfort.

    • Fever and diaphoresis.

    • Fatigue and loss of appetite.

    • Crackles and decreased air entry noted on chest auscultation.

    • Struggling to speak in full sentences.

    • Skin appearance: May appear moist, dusky, or cyanotic.

Management and Therapeutic Interventions for Pneumonia

  • Diagnostic assessment and prevention:

    • A fully comprehensive respiratory assessment.

    • Medical orders may include blood tests, a chest x-ray, and sputum specimens.

    • Maintenance of sterility, asepsis, and hand hygiene.

  • Clinical management:

    • Resting in bed in semi or high Fowler's position.

    • Administering antibiotics as prescribed.

    • Performing frequent respiratory assessments.

    • Goal-oriented care: Sit the patient out of bed and mobilize as tolerated as soon as possible.

    • Pain assessment and management.

    • Maintaining hydration and nutritional requirements.

    • Chest physiotherapy.

    • Administering oxygen therapy if indicated.

    • Alleviating anxiety and providing comfort/assistance with Activities of Daily Living (ADLsADLs).

    • Patient education to reduce the risk of acquiring pneumonia.

Pneumothorax: Pathophysiology and Classification

  • Definition: Caused by air entering the pleural cavity.

    • The change from negative to positive pressure in the pleural space causes partial or complete lung collapse.

    • As the volume of air in the pleural space increases, the lung volume decreases.

  • Symptoms based on size:

    • Small Pneumothorax: Mild tachycardia and dyspnea may be the only symptoms.

    • Large Pneumothorax: evident respiratory distress, shallow/rapid respirations, dyspnea, air hunger, tracheal deviation, oxygen desaturation, chest pain, and cough, no breath sounds on auscultation of the affected area.

  • Classified Types:

    • Spontaneous: Typically occurs due to the rupture of blebs on the apex of the lung.

    • Traumatic: Result of penetrating trauma (e.g., stabbing, gunshot wound) allowing air through chest wall openings, or non-penetrating trauma (e.g., rib fracture) lacerating the lung.

    • Tension Pneumothorax: Occurs when air enters the pleural space but cannot escape. This increases intrapleural pressure, compressing the lung and putting pressure on the heart and great vessels, pushing them away from the affected side.

Hemothorax and Pleural Effusion

  • Hemothorax:

    • Accumulation of blood in the pleural space resulting from injury to the chest wall, diaphragm, lung, blood vessels, or membranes.

    • Symptoms: Dyspnea, diminished/absent breath sounds, dullness on percussion, and decreased hemoglobin.

    • Shock may occur depending on the blood volume lost.

  • Pleural Effusion:

    • Abnormal collection of fluid in the pleural cavity; it is an indicator of disease rather than a disease itself.

    • Causes of accumulation: Increased pulmonary capillary pressure, decreased oncotic pressure, increased pleural membrane permeability, or obstruction of lymphatic flow.

    • Symptoms: Dyspnea, cough, and occasional sharp non-radiating chest pain that is worse on inhalation.

    • Signs: Decreased movement of the chest on the affected side, dullness on percussion, and diminished breath sounds over the affected area.

Pulmonary Edema: Mechanisms and Clinical Manifestations

  • Definition: Build-up of fluid in the interstitial space (tissue space between capillaries and alveoli), impairing gas exchange.

  • Cardiogenic Pathophysiology:

    • Most common cause: Left-sided heart failure.

    • The unhealthy left ventricle cannot pump effectively, causing blood to back up into the left atrium, pulmonary veins, and pulmonary capillaries.

    • Increased blood in capillaries leads to pulmonary hypertension (increased hydrostatic pressure), pushing fluid into the interstitial space.

    • Severe systematic hypertension (BP > 181/110) can also cause this due to high afterload.

  • Non-cardiogenic Pathophysiology:

    • Direct injury to alveoli or vasculature from pulmonary infections, toxic inhalation, or trauma.

    • Inflammatory response increases localized capillary permeability, allowing proteins and fluid into the interstitial space.

    • Sepsis: Causes systemic inflammation and global edema.

    • Low Oncotic Pressure: Results from low protein production (liver failure/malnutrition) or rapid protein loss (nephrotic syndrome), causing fluid to move into the interstitial space throughout the body.

  • General Signs and Symptoms:

    • Dyspnea, tachycardia, and anxiety.

    • Productive cough with pink frothy sputum.

    • Excessive sweating, cyanosis, and dungs on percussion.

    • End inspiratory crackles.

  • Heart Failure Specific Symptoms:

    • Shortness of breath when lying supine.

    • Episodes of breathlessness at night.

    • Peripheral pitting edema, raised jugular venous pressure, and an enlarged liver.

Pulmonary Embolism and V/Q Mismatch

  • Definition: Occurs when a blockage (typically a clot) becomes lodged in a pulmonary artery.

  • Origin: Most are thought to originate from leg veins above the knee.

  • Pathophysiology:

    • Lung tissue downstream from the blockage becomes inadequately perfused.

    • Ventilation-perfusion (V/QV/Q) mismatch: The tissue is ventilated with oxygen, but there is no blood to perfuse it.

    • Hyperventilation: Physiological response to offload CO2CO_2.

    • Respiratory alkalosis: An increase in blood pHpH caused by hyperventilation.

  • Signs and Symptoms:

    • Dyspnoea and pleuritic chest pain.

    • Cough and hemotipsis.

    • Fainting.

    • DVT symptoms: Tender, swollen, erythematous extremities.

Nursing Management of Intercostal Catheters (ICCs)

  • Maintenance and Assessment:

    • Conduct thorough and routine respiratory assessments.

    • The thoracic drain must be kept below the chest height and below the level of insertion to enable gravity drainage.

    • Assess from the insertion site along the entire length of the tube to the drainage system; ensure no kinks or occlusions.

    • Ensure the drain is secured per policy and monitor dressings throughout the shift.

  • Documentation and Patient Care:

    • Document drainage output (volume, rate, color, and characteristics), ear leaks, and swing.

    • Manage patient comfort and pain.

    • Educate and provide deep breathing, coughing, and mobilization exercises every 121-2 hours.

  • Assessment of Function:

    • Suction: Pause under supervision to assess ear leaks and swing.

    • Ear leaks: Assess frequency and timing (e.g., constant or on inspiration). Continuous leaks may indicate issues at the insertion site or connections.

    • Patency: Look for a swing (rise and fall) in one of the chambers.

Pathophysiology of Ischemia

  • Definition of Ischemia: Inadequate blood flow and therefore oxygenation to an organ or tissue.

  • Cellular Response to Compromised Oxygen Supply:

    • When blood flow and oxygen supply to cells are compromised, the production of ATPATP will decrease.

    • Anaerobic Respiration: In order to compensate for low energy, cells switch to anaerobic respiration to maintain ATPATP production.

    • Lactic Acid Accumulation: Consequently, lactic acid accumulates within the cells.

    • Mitochondrial Dysfunction: The accumulation of lactic acid disrupts the function of the mitochondria.

Consequences and Cellular Impacts of Ischemia

  • Dysfunction of Cell Membrane Pumps: Impaired ATPATP production causes the cell membrane pumps (such as the sodium-potassium pump) to fail.

  • Osmotic Pressure and Cellular Swelling:

    • Failure of membrane pumps results in an accumulation of sodium (Na+Na^+) ions within the cell.

    • This accumulation exerts strong osmotic pressure, which draws water into the cell.

    • Resulting effects include cellular swelling, damage to cell membranes, and disruption of organelle functions.

  • Calcium Ion Release:

    • Calcium ions (Ca2+Ca^{2+}) are released into the cytoplasm from intracellular stores.

    • This release activates intracellular enzymes that further impair mitochondrial function.

  • Toxic Waste Accumulation: Toxic waste products accumulate within the cell because they cannot be cleared, causing additional damage to cellular structures.

  • Long-term Outcome: Prolonged ischemia leads to infarction (tissue death) and necrosis.

Causes and Clinical Locations of Ischemia

  • Causes of Ischemia: Anything that impedes the delivery of oxygen, including:

    • Vasoconstriction.

    • Vasospasm.

    • Atherosclerosis.

    • Anemia.

    • Hemorrhage.

  • Common Clinical Locations and Outcomes:

    • Brain: Results in stroke (cerebrovascular accident).

    • Eyes: Results in vision deficits.

    • Heart: Can cause angina; symptoms typically progress rapidly.

    • Intestines: Can result in bowel obstruction.

    • Kidneys: Results in acute renal failure.

    • Limbs and Digits: Related to peripheral arterial disease or compartment syndrome (often as a result of a fracture).

Pathophysiology of Atherosclerosis

  • General Characteristics: Atherosclerosis is a vascular disorder usually associated with aging, obesity, high cholesterol intake, and hypertension.

  • Initial Injury: The process begins with an initiating event that causes damage to the endothelial cells lining the vessel.

  • Inflammatory Process:

    • Leukocytes are recruited to the site of injury.

    • Lipoproteins, Low Density Lipoprotein (LDL) and Very Low Density Lipoprotein (VLDLVLDL), infiltrate the vessel wall at the injury site into the subendothelial layer.

    • LDL Oxidation: The subsequent oxygenation (oxidation) of Low Density Lipoprotein (LDLLDL) attracts monocytes to the focal zone.

    • Cytokines and Growth Factors: These are released as part of the inflammatory process.

  • Vessel Wall Thickening: Smooth muscle cells in the vessel wall are stimulated to grow and enter the focal zone, causing the wall to thicken.

Plaque Development and Vessel stiffening

  • Foam Cell and Necrotic Core Formation:

    • Smooth muscle cells and monocytes (macrophages) consume the lipoproteins.

    • Toxicity: Oxidized LDLLDL becomes toxic at elevated levels, leading to cell death.

    • Debris: Deposition of dead cell debris, cholesterol crystals, and cellular contents forms a necrotic core in the vessel wall.

  • Fibrous Cap Formation:

    • The endothelium attempts to regenerate over the necrotic core.

    • Fibrin infiltrates the area, leading to the formation of a fibrous cap over the lesion.

  • Vessel Stiffening and Obstruction:

    • The combination of infiltration, plaque formation, and the fibrous cap leads to the stiffening of the vessel wall.

    • Established plaque often causes the vessel to become twisted, further impeding blood flow.

Risk Factors for Atherosclerosis

  • List of Risk Factors:

    • Hyperlipidemia.

    • Hypertension.

    • Cigarette smoking.

    • Insulin resistance.

    • Diabetes mellitus.

    • Lack of physical activity.

    • Obesity.

    • Unhealthy diet.

    • Obstructive sleep apnea.

Peripheral Vascular Disease (PVD)

  • Definition: The disruption of peripheral perfusion due to the obstruction of blood vessels and increased thrombogenesis.

  • Associations: Overwhelmingly associated with atherosclerosis and diabetes. It may also be associated with vasospasm, venous insufficiency, embolism, vasculitis, and fibromuscular dysplasia.

  • Primary Feature: Reduced peripheral perfusion leading to ischemia and potential tissue necrosis.

  • Claudication: Ischemia of skeletal muscle causes claudication, which is painful cramping in the limbs, hands, and feet. It is typically caused by exertion but can be experienced at rest.

Signs and Symptoms of PVD

  • Physical Findings:

    • Diminished or absent peripheral pulses.

    • Pallor or changes to skin color.

    • Tight, shiny, and thin skin.

    • Loss of leg hair.

    • Brittle nails.

    • Leg ulcers or gangrenous toes.

    • Paresthesia.

    • Claudication pain.

Management of Peripheral Vascular Disease

  • Early Intervention: Early diagnosis allows for interventions that slow or reduce disease progression.

  • Lifestyle Modifications:

    • Smoking cessation.

    • Maintaining an exercise and walking program.

    • Managing dietary factors contributing to atherosclerosis.

  • Physical Precautions:

    • Ensuring the dependent position of the legs (hanging down) where possible.

    • Avoiding skin trauma.

    • Wearing correctly fitting shoes to reduce pressure.

  • Surgical Management: Such as a femoral popliteal bypass.

Acute Coronary Syndrome (ACS) and Angina

  • Definition of ACS: A collective term for conditions resulting in myocardial ischaemia, which is the alteration of blood flow to a part of the myocardium. This includes angina and myocardial infarction.

  • Angina Pectoris: Categorized by attacks of chest pain caused by insufficient oxygenation of the heart.

  • Three Forms of Angina:

    1. Stable Angina: Caused by atherosclerotic plaque and inappropriate vasoconstriction. Blood flow is adequate at rest but compromised during exertion.

    2. Unstable Angina: Caused by atherosclerotic plaque and associated thrombus, resulting in a greater degree of vascular obstruction. Blood flow is compromised even at rest.

    3. Variant Angina: Caused by unexplained vasospasms in the absence of atherosclerotic plaque. It occurs in conjunction with STST elevation; pain can occur at any time without a recognized trigger.

Myocardial Infarction (MI): Pathophysiology and Classification

  • Definition: A condition causing the death of a region of the myocardium resulting from an obstruction in blood flow.

  • Classification by ST Segment:

    • STEMI (ST Elevation MI): Thrombus causing complete obstruction.

    • NSTEMI (Non-ST Elevation MI): Presence of a partial or transiently obstructive thrombus.

  • Classification by Cause: For example, Type 1: Caused by the spontaneous rupture or erosion of atherosclerotic plaque.

  • Pathophysiology of Plaque Rupture:

    1. Fibrous cap of the plaque ruptures.

    2. Subendothelial collagen is exposed.

    3. Platelets are attracted and activated.

    4. A platelet plug forms and traps red blood cells.

    5. The Coagulation Cascade converts the plug into a thrombus by laying down fibrin.

    6. The thrombus grows and spreads along the damaged vessel, decreasing blood flow and initiating ischemia.

Clinical Manifestations and Management of MI

  • Signs and Symptoms:

    • Increased heart rate.

    • Increased respiratory rate.

    • Diaphoresis (excessive sweating).

    • Nausea and vomiting.

    • Chest pain.

    • Impending sense of doom.

  • Diagnostic Assessment: Begins with an ECG, history, physical examination, and cardiac troponin values.

  • Therapeutic Management:

    • Suspected or confirmed ACS should receive aspirin and analgesia.

    • STEMI Management: Requires immediate and urgent reperfusion.

    • NSTEMI Management: Evaluated further to guide the need for invasive management.

    • Unstable Angina: Focuses on risk assessment, stabilization, and management.

  • Patient Education: Stress the importance of diet, regular physical activity, smoking cessation, and limiting alcohol as these are modifiable risk factors.

Cerebrovascular Accident (Stroke)

  • Definition: A cerebrovascular lesion that develops suddenly within the cerebral circulation, causing the vessel to become blocked or bleed, compromising blood supply to the brain.

  • Result: Cerebral infarction, causing neurons in the affected area to die.

  • Ischaemic Stroke: Result of a sudden obstruction (thrombus or embolus) to a cerebral artery. The brain region becomes ischaemic and will quickly infarct and suffer irreversible damage if not improved.

    • Thrombus: A clot that forms and stays in one place; typically associated with plaque, hypercoagulability (due to immobility), or blood stasis (as in atrial fibrillation).

    • Embolus: An object (detached clot, fat, air, or tumor) that travels through the bloodstream and blocks a vessel elsewhere.

  • Hemorrhagic Stroke: Occurs when a cerebral artery ruptures, causing bleeding into the brain tissue and loss of blood supply to the vessel's target area. Contributed to by chronic hypertension, aneurysms, or arteriovenous malformations.

Stroke Risk Factors and Co-morbidities

  • Modifiable Risk Factors: Hypertension, diabetes mellitus, smoking status, alcohol consumption, and hyperlipidemia.

  • Non-modifiable Risk Factors: Age, family history, and prior stroke or transient ischemic attack (TIATIA).

  • Co-morbidities Increasing Risk:

    • Coronary artery disease (CADCAD).

    • Peripheral vascular disease (PVDPVD).

    • Asymptomatic carotid stenosis.

    • Atrial fibrillation.

Cardiac Conduction and Cellular Electrophysiology

  • Definitions:

    • Conductivity: The ability to transmit an impulse along a membrane in an orderly manner.

    • Contractility: The ability to respond mechanically to an impulse.

  • Conduction Pathway: Sinoatrial (SASA) node -> Atria (causing contraction) -> Atrioventricular (AVAV) node -> Bundle of His -> Bundle branches -> Purkinje fibres -> Ventricles (causing contraction).

  • Membrane Potential and Ion Movement:

    • Inside cell: High concentration of Potassium (K+K^+) and low Sodium (Na+Na^+).

    • Outside cell: High concentration of Sodium (Na+Na^+) and low Potassium (K+K^+).

    • Depolarization: Stimulation changes membrane permeability, allowing Na+Na^+ to flow rapidly into the cell, making the inside positive.

    • Repolarization: Slower movement of ions restores the polarized state.

Electrocardiogram (ECG) Monitoring and Accuracy

  • Definition: A graphic tracing of the electrical activity of the heart, visualizing depolarization and repolarization.

  • Diagnostic Uses: Highlights electrical changes suggesting structural changes, conduction disturbances, electrolyte balance, medication toxicity, and arrhythmias.

  • ECG Paper Measurements:

    • One small square (1mm1\,mm) = 0.04s0.04\,s.

    • One large square = 0.2s0.2\,s.

    • 300300 large squares = 1min1\,min.

  • Calculating Heart Rate:

    • Method 1: Count the number of QRSQRS complexes in one minute (most accurate).

    • Method 2: Count the number of RR to RR intervals in 6s6\,s and multiply by 1010.

Components of the ECG Waveform

  • P Wave: Represents passage of impulse through the atria causing atrial depolarization; should be upright. Duration: 0.060.06 to 0.12s0.12\,s.

  • PR Interval: From beginning of the P wave to beginning of the QRSQRS complex; represents spread of impulse through the conduction system prior to ventricular contraction. Duration: 0.120.12 to 0.2s0.2\,s.

  • QRS Complex: Represents time for depolarization of both ventricles. Duration: Less than 0.12s0.12\,s.

  • ST Segment: From the S wave to the beginning of the T wave; represents time between ventricular depolarization and repolarization. Should be isoelectric (flat). Duration: 0.12s0.12\,s.

  • T Wave: Represents time for ventricular repolarization; should be upright. Duration: 0.16s0.16\,s.

Cardiac Dysrhythmias: Sinus and Atrial Rhythms

  • Sinus Rhythm: Characterized by a round, symmetrical P wave, narrow QRS complex, round symmetrical T wave, and 60-100bpm. Normal heart rhythm.

  • Sinus Tachycardia: Same pathway as sinus rhythm but with increased discharge rate (101101 to 200bpm200\,bpm) due to vagal inhibition or sympathetic stimulation. Symptoms: dizziness, dyspnea, hypertension.

  • Sinus Bradycardia: SASA node firing at less than 60bpm60\,bpm . Symptoms: pale/cool skin, hypertension, weakness, dizziness, syncope, shortness of breath.

  • Atrial Fibrillation (AF): Irregular rhythm. Atrial rate: 350350 to 600bpm600\,bpm. Ventricular rate: 6060 to 100bpm100\,bpm (controlled) or 100100 to 200bpm200\,bpm (uncontrolled).

    • AF Nursing Considerations: Check BP/HR/RR for changes; monitor stroke risk; check for anticoagulants.

  • Atrial Flutter: Regularly irregular rhythm. Distinctive feature is the "sawtooth baseline" P wave, obscured T wave. Atrial rate: 250250 to 450bpm450\,bpm. Nursing considerations match those of AF.

Ventricular Dysrhythmias and Life-Threatening Conditions

  • Ventricular Tachycardia (VT):

    • Rhythm: Wide and bizarre, usually regular.

    • QRSQRS: Wide and bizarre; T wave in the opposite direction.

    • Rate: Ventricular rate 100100 to 200bpm200\,bpm.

    • Nursing: Call medical staff/MET call immediately; print rhythm strip; initiate CPR if patient is unconscious.

  • Ventricular Fibrillation (VF):

    • Description: Irregular, disorganized waves with no form; unable to determine any waves/intervals. Starts as coarse fibrillatory waves and progresses to fine waves.

    • Condition: Life-threatening with no cardiac output; patient will be unconscious.

    • Nursing: Call code blue; follow CPR guidelines.

  • Asystole: Known as a "flatline." Patient is unconscious. Nursing: Check electrode connections immediately; if connected correctly and asystole continues, commence CPR.

Classification and Pathophysiology of Bowel Obstructions

  • Bowel obstructions are clinically significant disruptions to the flow of intestinal contents and are categorized by their underlying etiology:

    • Structural Obstructions: Physical barriers preventing the passage of contents.

      • Internal Causes: Originating within the lumen, such as fecal impaction.

      • External Causes: Also known as extra-luminal forces, these involve compression from outside the intestinal wall (e.g., external compression of a section of the intestine).

    • Functional Obstructions: Generally related to smooth muscle dysfunction which impairs normal peristalsis despite the absence of a physical blockage.

  • Classifications of Severity:

    • Complete Obstruction: Total occlusion of the intestinal lumen.

    • Partial Obstruction: The lumen is partially narrowed; however, even partial obstructions are considered dangerous if they significantly restrict the passage of contents.

Structural Obstructions of the Small Bowel

Small bowel structural obstructions are most commonly caused by extra-luminal forces, specifically hernias and adhesions.

Hernias
  • Definition: A hernia occurs when a loop of intestine protrudes through a point of weakness in the muscular wall of the abdominopelvic cavity.

  • Clinical Categorization:

    • Uncomplicated Hernia: The protruding loop of intestine is capable of spontaneously retracting back into the abdominal cavity.

    • Incarcerated Hernia: Spontaneous retraction is impossible. The loop can be compressed by the surrounding muscle wall, leading to the obstruction of the intestinal lumen.

    • Strangulated Hernia: Occurs when the compression is severe enough to compromise blood flow. This leads rapidly to ischemic tissue damage.

  • Signs and Symptoms: These vary based on location and severity.

    • Incarceration Signs: Nausea, vomiting, and pain.

    • Strangulation Signs: Clinical signs of sepsis, tachycardiatachycardia, and fever.

  • Management:

    • Manual reduction performed under sedation.

    • Surgical repair of the underlying muscular defect.

Adhesions
  • Definition: Bands of scar tissue that grow between organs or between organs and the cavity walls within the abdominopelvic cavity.

  • Etiology:

    • Post-abdominal surgery.

    • Post-peritonitis (inflammation of the peritoneum).

    • CrohnsdiseaseCrohn's\,disease.

  • Mechanism of Obstruction: Adhesions can trap sections of the intestine (similar to a hernia) or cause sharp kinks to form, obstructing the normal flow of intestinal contents.

  • Symptoms: Abdominal pain, loss of appetite, vomiting, and constipation.

Intussusception
  • Mechanism: Occurs when a proximal section of the intestine folds into an adjacent distal section, similar to a telescope being closed.

  • Consequences: Within this telescoped region, the lumen is narrowed and local blood vessels are squeezed.

  • Symptoms: Related to the obstruction, including abdominal pain, vomiting, and loss of appetite.

  • Management: A barium enema is typically used to reduce the telescoping. If reduction fails or if perforation occurs, surgery is required.

Volvulus
  • Definition: Occurs when a loop of intestine twists 360360^{\circ}.

  • Consequences: This full rotation completely occludes the intestinal lumen and collapses the associated blood vessels.

Structural Obstructions of the Large Intestine

  • Colorectal Cancer: The most significant and primary cause of obstruction in the large intestine.

  • Diverticular Disease:

    • Diverticula: Pouches formed when the mucosa and submucosa balloon out through defects in the muscular wall of the intestine.

    • Etiology: Most common in individuals consuming a low-fiber diet. Low fiber leads to hard feces, which require high pressure to move through the intestine. These high pressures induce structural ballooning.

    • Diverticulosis: The presence of asymptomatic diverticula.

    • Diverticulitis: Inflammation and infection of the diverticula, often caused by fecal compaction within the pouches.

    • Symptoms of Diverticulitis: Left lower quadrant pain, nausea, vomiting, changes to bowel habits (such as diarrhea), and bloating. Severe cases involving perforation can lead to peritonitis and sepsis.

    • Management: Severity-dependent; include increasing dietary fiber, antimicrobials, and probiotics.

Functional Intestinal Obstruction (Ileus)

  • Definition: Reduced intestinal motility causing failure of content movement despite the absence of a physical blockage. This is specifically termed an ileusileus.

  • Pathophysiology: Failure of peristaltic contractions in the smooth muscle of the intestinal wall. This leads to the accumulation of fluid and gas, resulting in a distended and tender abdomen.

  • Etiology:

    • Abdominal surgery (the most common cause).

    • Systemic infection.

    • hypokalemiahypokalemia (electrolyte imbalance).

    • Peritonitis.

    • Intestinal ischemia.

  • Symptoms: Abdominal pain, vomiting, and loss of appetite.

  • Management:

    • Patient must remain "nil by mouth" (NBM) until the ileusileus resolves.

    • Stimulation of motility through mobilization (walking) or chewing gum.

    • Many cases resolve with minimal intervention beyond symptom relief.

Comparison of Obstruction Types

  • Large Bowel & Complete Small Bowel Obstructions: Typically present with complete constipation and severe abdominal pain.

  • Partial Obstructions (Either Bowel): Likely to present with mild pain, distension, vomiting, and constipation.

Appendicitis

  • Anatomy: The appendix is a hollow tube; therefore, inflammation is primarily caused by an obstruction.

  • Etiology of Obstruction:

    • Faecalith (hardened stool).

    • Undigested seeds.

    • Pinworm infection.

    • Swelling and increased activity of subepithelial lymphoid tissue (often following an earlier infection).

  • Pathophysiology (Step-by-Step):

    1. Blockage: The lumen is obstructed.

    2. Fluid Accumulation: Mucus and fluid continue to be produced by the epithelium, causing the appendix to distend.

    3. Pressure Increase: Increased pressure stimulates nearby nerve fibers, causing pain.

    4. Bacterial Proliferation: Trapped flora and intestinal bacteria replicate rapidly.

    5. Epithelial Damage: High pressure damages the epithelial barrier, allowing bacteria to invade underlying tissue layers and trigger an inflammatory response.

    6. Ischemia and Necrosis: Persistent pressure compresses blood vessels, leading to ischemia (oxygen deprivation) and eventual necrosis of the tissue.

    7. Rupture: The necrotic wall may rupture, releasing bacteria and pus into the peritoneal cavity.

  • Complications: Rupture leads to peritonitis.

  • Symptoms: Pain localized to the Right Lower Quadrant (RLQ), fever, loss of appetite, nausea, abdominal guarding, and rigidity.

  • Management: Appendectomy is the standard treatment, typically accompanied by prophylactic antimicrobial use.

Soft Tissue Injuries and Joint Displacement

  • Sprain

    • Definition: An injury specifically involving a ligament.

    • Mechanism: Occurs when a twisting or stretching action forces the joint to move beyond its normal physiological range of movement.

  • Strain

    • Definition: A stretching or tearing injury occurring in a muscle or a tendon.

    • Anatomical Context: The tendon is the tissue that connects muscle to bone.

    • Mechanism: Generally caused by actions that continue beyond the normal range of movement for the affected joint.

  • Dislocation (Luxation)

    • Definition: The displacement of one or more ends of articulating bones at a joint.

    • Mechanism: Extreme force causes significant ligament damage, resulting in the total separation of two bones.

    • Associated Damage: Dislocation can cause extensive secondary damage to surrounding ligaments, blood vessels, and nerves.

    • Compression Damage: When a joint is malpositioned, soft structures, vessels, and nerves can become trapped between the displaced bones, leading to compression damage.

    • Stability Principle: There is an inverse relationship between range of motion and stability; the greater the range of motion a joint provides, the less stable it is and the more prone it is to dislocation.

  • Subluxation

    • Definition: A partial dislocation of one or more ends of the articulating bones.

    • Impact: While vessel and nerve entrapment remain possible, ligament damage is typically less severe than that seen in a full dislocation.

  • Avulsion

    • Definition: The forcible detachment of a tendon, ligament, muscle, or bone from its original point of attachment.

    • Bone Fragment: A small fragment of bone may also be removed along with the detached soft tissue.

Chronic and Overuse Musculoskeletal Conditions

  • Bursitis

    • Definition: Inflammation and the accumulation of fluid within the subcutaneous bursae.

    • Etiology: Often results from excessive repetitive use or prolonged pressure applied to a joint.

  • Tendinitis

    • Etiology: Occurs as a result of chronic overuse.

    • Exacerbating Factors: Presence of poor posture, obesity, or poor physical technique.

Clinical Presentation of Soft Tissue Injuries

  • General Presentations

    • Pain.

    • Decreased range of motion (ROM).

    • Localized edema (swelling).

  • Specific Presentations

    • Tendon Rupture: If a complete rupture occurs, there may be a visible void or deformity in the area, along with a palpable lump proximal to the injury where the tendon has retracted.

    • Dislocation: The joint will generally appear visibly deformed.

    • Vascular Compromise:

      • Skin Appearance: Pale and cool to the touch.

      • Pulses: Peripheral pulses may be reduced or absent.

      • Capillary Refill: Slow (greater than 2seconds2\,\text{seconds}).

      • Urgency: Vascular compromise is considered limb-threatening and requires urgent medical attention.

    • Tendinitis and Bursitis: Characterized by persistently swollen and painful joints, often accompanied by muscle weakness and decreased ROM.

Management and First Aid for Musculoskeletal Injuries

  • Assessment Protocol

    • Conduct a primary survey followed by a detailed secondary survey.

    • Affected Limb Assessment: Observe for color, warmth, movement, sensation, capillary refill, and peripheral pulses.

    • History: Obtain a full medical history and a description of the mechanism of injury (MOI).

    • Pain: Perform pain assessments frequently.

  • RICER Mnemonic for First Aid

    • Rest.

    • Ice.

    • Compression.

    • Elevation: Caution: Do not elevate the limb if neurovascular compromise is detected, as this can further impair blood supply.

    • Referral: Necessary for cases of dislocation or avulsion (often requiring a surgical team).

  • Neurovascular Observations of Concern

    • Color: White/pale, cyanotic (blue), or mottled.

    • Temperature: Cool or cold skin.

    • Movement: Severe pain upon movement, limited movement in specific directions, or total loss of movement.

    • Sensation: Inability to distinguish touch in all areas, paresthesia (pins and needles), or total absence of sensation.

    • Capillary Refill: Blanching does not resolve in less than 2seconds2\,\text{seconds}.

    • Pulses: Diminished or absent peripheral pulses.

  • Patient Education: The NO HARM Acronym

    • No Heat: Avoid for at least 24hours24\,\text{hours} as it exacerbates swelling and alters pain perception.

    • No Alcohol: Avoid for at least 24hours24\,\text{hours}; like heat, it increases swelling and masks pain, risking further injury.

    • No Running: Cease exercise immediately as it increases blood flow to the area, worsening edema.

    • No Massage: Avoid for at least 72hours72\,\text{hours} to reduce the risk of internal bleeding.

Types of Fractures and Classifications

  • Open Fracture: Results in a breach of skin integrity (bone may protrude).

  • Closed Fracture: The skin remains intact over the site of the fractured bone.

  • Transverse Fracture: The bone is broken at a right angle to its long axis.

  • Spiral Fracture: Result of twisting forces; the fracture line wraps around the length of the bone.

  • Comminuted Fracture: The bone splinters or breaks into more than three fragments.

  • Longitudinal Fracture: The fracture line extends along the length of the bone.

  • Segmental Fracture: Multiple fractures resulting in a free-floating section of bone across the shaft.

  • Oblique/Diagonal Fracture: The fracture extends across the shaft in a diagonal manner.

  • Avulsion Fracture: A section of bone is torn away at the site where a ligament is detached.

  • Classification by Stability:

    • Stable Fractures: May only require splinting and protection for pain relief.

    • Unstable Fractures: Require invasive intervention such as internal or external fixation.

Clinical Assessment and Neurovascular Monitoring of Fractures

  • General Clinical Presentation

    • Pain and swelling.

    • Loss of function.

    • Obvious deformity (due to displacement or edema).

    • Crepitus: A grinding sound or sensation heard when the ends of broken bones rub together.

  • Detailed Physical Assessment

    • Review medical history, MOI, prior musculoskeletal injuries, and current medications.

    • Peripheral Vascular Component: Assess color, temperature, capillary refill, peripheral pulses, and presence of edema.

      • Pallor and cool temperature: May indicate arterial compromise.

      • Warm but cyanotic extremity: May indicate venous congestion or insufficiency.

      • Absent/Diminished pulses: Indicates vascular dysfunction from swelling pressure or direct trauma.

    • Peripheral Neurological Component: Assess sensation, motor function, and pain.

      • Upper Extremities: Check ulnar, median, and radial nerve function.

      • Lower Extremities: Check peroneal and tibial nerves via dorsiflexion and plantar flexion.

    • Regional Focus: Always focus on the region distal to the injury site and compare both limbs to establish a baseline and severity.

The Biological Process of Bone Healing

  • Stage 1: Hematoma Formation

    • Mechanism: Blood collects at the fracture site due to lacerated vessels.

    • Clot Composition: A large clot forms, rich in fibrin, fibroblasts, macrophages, monocytes, and lymphocytes.

    • New vessels begin to form around and into the clot.

    • Cellular Activity: Osteoblasts and osteoclasts proliferate; within 48hours48\,\text{hours}, osteoclasts begin removing necrotic bone tissue.

  • Stage 2: Fibrocartilaginous Callus Formation

    • Early granulation tissue forms.

    • Fibroblasts and osteoblasts lay down collagen fibers to bridge the fracture and fragments.

    • Chondroblasts form patches of cartilage.

    • Osteoblasts lay down the bone matrix (osteoid).

    • Timeline: A soft callus is formed within 1week1\,\text{week}.

  • Stage 3: Ossification

    • The callus (osteoid, cartilage, and collagen) undergoes mineralization with calcium and mineral salts.

    • Result: Becomes a hard callus.

    • Timeline: Starts within a month and continues for approximately 3months3\,\text{months}.

  • Stage 4: Remodeling

    • Osteoblasts lay new bone to strengthen the fracture site.

    • Osteoclasts remove excess bone and reshape the structure to its original form.

    • Timeline: Can take several years to complete.

Complications Associated with Fractures

  • Fat Embolism Syndrome (FES)

    • Risk: Associated with long bone fractures where fat nodules from the marrow enter circulation.

    • Theories: Mechanical (direct entry) and Biochemical (production of toxic metabolites from fat degradation).

    • Observations: Signs of hypoxia, wheeze or crackles (lung auscultation), chest pain on inspiration, increased heart rate (tachycardia), and increased temperature (fever).

    • Management: Prevention through careful immobilization, deep breathing, and coughing exercises.

  • Deep Vein Thrombosis (DVT)

    • Etiology: Blood clot in a large vein due to decreased blood flow (reduced mobility), injury to vessel walls, and altered coagulation (active blood loss).

    • Observations: Swelling, pain, tenderness, and cramping in the extremity.

    • Management: Early immobilization, early ambulation (especially post-surgery), prophylactic anticoagulation therapy, and use of TED (thrombo-embolic deterrent) stockings.

  • Compartment Syndrome

    • Definition: Excessive pressure builds within a muscle compartment bound by non-stretching fascia.

    • Pathophysiology: Inflammation or external restriction (tight cast/bandage) increases internal pressure, compressing capillaries and nerves. This reduces perfusion, leading to ischemia and cellular damage.

    • Observations: Intense pain (especially on passive stretch), paresthesia, paralysis, pallor, cool temperature, reduced peripheral pulses, and a palpably tense compartment.

    • Management:

      • Immediate neurovascular observations and escalation.

      • Do NOT elevate (increases pressure).

      • Do NOT apply ice (increases vasoconstriction).

      • Loosen tight dressings/casts.

      • Fasciotomy may be required for internal causes to relieve pressure.

Nursing Management: Pre-operative and Post-operative Care

  • Pre-operative Care

    • Education: Inform the patient about the level of immobilization and assistive devices (e.g., crutches).

    • Analgesia: Assure the patient that adequate pain relief will be maintained.

    • Skin Prep: Routine cleaning and hair removal if necessary.

  • Post-operative Care

    • Monitor vital signs and perform frequent neurovascular assessments.

    • Repositioning: Assist with repositioning and support the extremity to minimize pain.

    • Wound/Cast Care: Observe for bleeding or drainage. Ensure wound drains are patent and monitor drainage volume.

    • Systemic Considerations: Monitor for constipation (high fluid/fiber intake), encourage activity, and facilitate cardiovascular function (e.g., sitting out of bed with dangling legs).

  • Discharge and Education

    • Cast care instructions.

    • Elevation: Encourage limb elevation above the heart level and ice application (if no compartment syndrome) to control edema.

    • Proper use of assistive mobility devices.

Primary Survey: Purpose and Immediate Management

  • Purpose of the Primary Survey: The primary objective is to promptly identify and manage life-threatening conditions and to identify any emergent concerns.

  • CABCDE Assessment Framework:

    • Catastrophic Hemorrhage: Identify and manage large external blood loss immediately.

    • Airway: Ensure patency; includes cervical mobilization if the clinical situation necessitates it.

    • Breathing: Evaluate the ability to ventilate.

    • Circulation: Assess perfusion and hemodynamics.

    • Disability: Evaluate neurological status.

    • Exposure and Environment: Full assessment while maintaining patient dignity and temperature.

Step-by-Step Clinical Assessment and Procedure

  • Catastrophic Hemorrhage:

    • Identification: Look for signs of significant external blood loss.

    • Immediate Management: Apply direct pressure, use hemostatic dressings, and apply tourniquets as required.

  • Airway Management:

    • Assessment: Attempt to elicit a verbal response to check for consciousness and airway clarity.

    • Signs of Obstruction: Look and listen for accessory muscle use, uneven chest rise and fall, and upper airway noises.

    • Physical Checks: Inspect for displaced dentures.

    • Interventions: Open the airway using the chin lift and jaw thrust techniques; use suctioning if clinical indicators are present.

  • Breathing Assessment:

    • Vital Signs: Monitor respiratory rate, effort, and oxygen saturation.

    • Physical Inspection: Inspect the chest for wounds, bruising, or deformity.

    • Clinical Examination: Auscultate for bilateral air entry and palpate for tenderness or crepitus.

  • Circulation Assessment:

    • Vitals and Physical Signs: Evaluate pulse (quality and rate), skin color, temperature, and blood pressure.

    • Vascular Signs: Inspect for jugular vein irregularities.     Interventions: Insert IV access and apply a pelvic binder if the situation is indicated.

  • Disability (Neurological):

    • AVPU Scale: Assess if the patient is Alert, responds to voice, responds to pain, or is unresponsive.

    • Pupillary Assessment: Check pupillary size and response to light.

    • Metabolic Check: Test blood glucose levels.

  • Exposure and Environment:

    • Inspection: The patient should be fully exposed to facilitate the identification of hidden injuries.

    • Ethical Considerations: Exposure should be performed sequentially to maintain the patient's dignity.

    • Thermoregulation: Ensure the patient is kept warm to prevent hypothermia.

Fluid Imbalances: Hypovolemia and Hypervolemia

  • Hypovolemia (Extracellular Fluid Volume Deficit):

    • Pathophysiology: Occurs due to abnormal loss of body fluids, inadequate fluid intake, or a shift of fluid from plasma to the interstitial space.

    • Primary Causes:

      • Excessive diuresis secondary to diabetic hypoglycemia.

      • Overuse of diuretic medications.

      • Diabetes insipidus (inadequate secretion of or responsiveness to antidiuretic hormone, leading to poor water reabsorption in the renal distal tubules).

    • Distinction: Hypovolemia and dehydration are not synonymous. Dehydration refers specifically to the loss of pure water alone without the corresponding loss of sodium.

    • Clinical Presentation:

      • Restlessness, drowsiness, and confusion.

      • Thirst and dry mucous membranes.

      • Decreased skin turgor and increased temperature.

      • Postural hypertension and dizziness.

      • Increased heart rate and increased respiratory rate.

      • Decreased urine output and concentrated urine.

      • Weight loss.

  • Hypervolemia (Extracellular Fluid Volume Excess):

    • Pathophysiology: Occurs due to excess intake of IV fluids, abnormal retention of fluids, or a shift of fluid from the interstitial space into the plasma fluid.

    • Risk Factors: Long-term corticosteroid use is a notable cause.

    • Clinical Presentation:

      • Headache, confusion, and lethargy.

      • Peripheral edema and jugular vein distension.

      • S3S3 heart sound.

      • Increased blood pressure and a bounding pulse.

      • Dyspnea, crackles, and pulmonary edema.

      • Muscle spasms and weight gain.

Nursing Management and Serum Reference Levels

  • Nursing Management of Fluid Imbalance:

    • Performing daily weights and tracking fluid input and output.

    • Monitoring laboratory values and vital signs.

    • Performing detailed cardiovascular assessments as required.

    • Monitoring oxygen saturation and auscultating lungs.

    • Administering IV fluids as ordered by the medical team.

  • Normal Electrolyte Serum Levels:

    • Sodium: 135145mmolL1135-145\,mmol\,L^{-1}

    • Potassium: 3.55.2mmolL13.5-5.2\,mmol\,L^{-1}

    • Calcium: 2.12.6mmolL12.1-2.6\,mmol\,L^{-1}

    • Phosphate: 0.751.5mmolL10.75-1.5\,mmol\,L^{-1}

    • Magnesium: 0.71.1mmolL10.7-1.1\,mmol\,L^{-1}

    • Chloride: 95110mmolL195-110\,mmol\,L^{-1}

    • Bicarbonate: 2232mmolL122-32\,mmol\,L^{-1}

  • Normal Full Blood Examination (FBE) Levels:

    • Hemoglobin (Males): 130180gL1130-180\,g\,L^{-1}

    • Hemoglobin (Females): 120160gL1120-160\,g\,L^{-1}

    • White Blood Cells (WBC): 4.011.0×109L14.0-11.0\times109\,L^{-1}

    • Platelets: 150400×109L1150-400\times109\,L^{-1}

Detailed Analysis of Sodium and Potassium Imbalances

  • Hyponatremia (Low serum sodium concentration):

    • Types:

      • Hypertonic or Dilutional Hyponatremia: Occurs with excessive water gain, excess loss of sodium, or decreased renal water excretion.

      • Hypertonic or Translocational Hyponatremia: Develops when significant increases in extracellular solutes draw water into the extracellular compartment.

    • Common Causes: Excessive sodium loss (vomiting, diarrhea, burns), excessive water gain (thirst, congestive heart failure, water intoxication, hypertonic IV fluids), decreased excretion due to inaapropriate ADH secretion, and water shifts from intracellular to extracellular compartments (hyperglycemia, hyperproteinemia).

    • Clinical Presentation: Primarily characterized by cellular swelling, most notable in the central nervous system. Symptoms include headache, malaise, nausea, vomiting, muscle weakness, altered consciousness, edema, and seizures.

  • Hypernatremia (Excess serum sodium concentration):

    • Pathophysiology: Causes cellular dehydration and shrinkage.

    • Common Causes: Gain in sodium (hypertonic saline, salt tablets, impaired thirst cues) or excessive loss of water (fever, insufficient intake, refused sweating).

    • Clinical Presentation: Thirst, confusion, nausea, vomiting, altered consciousness, seizures, and hypertension.

  • Hypokalemia (Low serum potassium levels):

    • Note: Potassium is critical for muscle and nerve function.

    • Common Causes: Decreased intake (malnutrition, appetite loss), translocation shift (alkalosis, insulin administration, beta-two agonist therapy), or increased losses (diarrhea, vomiting, laxative misuse, hyperaldosteronism, corticosteroid therapy).

    • Clinical Presentation: Skeletal muscle weakness, fatigue, mental confusion, reduced bowel sounds, paralytic ileus, cardiac dysrhythmias, hypertension, polyuria, and vomiting.

  • Hyperkalemia (Elevated serum potassium levels):

    • Common Causes: Rapid intake (IV infusion, drugs with potassium salts), shifts from intracellular to extracellular space (acidosis, crush injuries, beta-receptor antagonism, digoxin toxicity), or decreased losses (potassium-sparing diuretics, chronic kidney disease, ACE inhibitors, hypoaldosteronism).

Sepsis: Identification, Progression, and Management

  • Definition of Sepsis: Life-threatening organ dysfunction caused by a dysregulated host response to infection; the immune system damages the body's own tissues and organs while fighting infection.

  • Pathophysiological Progression:

    1. Inflammatory stimulus enters the system.

    2. Endothelium releases chemical mediators.

    3. Subsequent vasodilation and capillary leakage.

    4. Initiation of the clotting cascade.

    5. Uncontrolled systemic clotting and depletion of clotting factors (the point at which something goes wrong).

    6. Intravascular volume deficit and prolonged corticosteroid release.

    7. Decreased tissue perfusion leading to organ dysfunction, multiple organ failure, and death.

  • Symptom Presentation in Adults:

    • Fast breathing and breathlessness.

    • Fever, chills, or low body temperature.

    • Low or no urine output.

    • Fast heartbeat, fatigue, pain, and a feeling of being "worse than ever."

    • Nausea, vomiting, diarrhea, confusion, and drowsiness.

  • Symptom Presentation in Children:

    • Fast breathing and long pauses between breaths.

    • Blotchy or discolored skin; skin cold to the touch.

    • A rash that does not blanch.

    • Low urine output and difficulty waking or confusion.

    • Restless behavior, floppy limbs, vomiting, and fits or convulsions.

    • Unexplained pain.

  • Lactate Enhanced Quick Sepsis Related Organ Failure Assessment (LQSOFA):

    • Used as a bedside tool to identify sepsis.

    • Criteria:

      1. Low systolic blood pressure: under 100mmHg100\,mmHg.

      2. High respiratory rate: greater than 2222 breaths per minute.

      3. Altered consciousness: Glasgow Coma Scale (GCS) less than 1515.

      4. Abnormal serum lactate: Normal levels are less than 1mmolL11\,mmol\,L^{-1}.

    • Scoring: The presence of abnormal lactate plus two other criteria indicates severe sepsis.

  • Adult Sepsis Pathway (60-Minute Actions):

    • Oxygen administration.

    • Collection of two sets of blood cultures.

    • Venous blood lactate measurement.

    • Fluid resuscitation with crystalloid to restore intravascular volume.

    • Administration of appropriate antibiotics.

    • Ongoing monitoring of vital signs and fluid balance.

Fluid Dynamics in Sepsis

  • Fluid Shifts: Vasodilation and capillary leakage cause fluid to move from the intravascular space to the interstitial spaces. This results in an intravascular fluid volume deficit and interstitial fluid volume excess.

  • Complications: If untreated, this leads to hypovolemia, which if prolonged can decrease tissue perfusion and cause organ failure.

  • Intravenous Fluid Therapy:

    • Crystalloid Solutions: (e.g., 0.9%0.9\% normal saline, compound sodium lactate). These increase volume in both intravascular and interstitial spaces. Isotonic solutions can be infused rapidly to increase blood volume, though they may cause peripheral edema.

    • Colloid Solutions: (e.g., 4%4\% albumin). These cause fluid to move from the interstitial space back into the vascular compartment.